Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages 137-150 , September 2006

Recognition and Stabilization of Neonates with Congenital Heart Disease

  • Shelly Fleiner, MS, RNC

      Affiliations

    • Corresponding Author InformationAddress correspondences to Shelly Fleiner, MS, RNC, Banner Children's Hospital at Banner Desert Medical Center, 1400 S. Dobson Road, Mesa, AZ 85202.

References 

  1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900
  2. Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics. 2005;116:e833–e838
  3. Coleman KB. Genetic counseling in congenital heart disease. Crit Care Nurs Q. 2002;25:8–16
  4. Rychik J. Frontiers in fetal cardiovascular disease. Pediatr Clin North Am. 2004;51:1489–1502
  5. Stauffer NR, Murphy K. Prenatal diagnosis of congenital heart disease: the beginning. Crit Care Nurs Q. 2002;25:1–7
  6. Rychik J, Ayres N, Cuneo B, et al. American society of echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr. 2004;17:803–810
  7. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics. 2003;111(5 Part 2):1152–1158
  8. Bahado-Singh RO, Wapner R, Thom E, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol. 2005;192:1357–1361
  9. Makrydimas G, Sotiriadis A, Ioannidis JP. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol. 2003;189:1330–1335
  10. Sparkes R, Chernos J, Dicke F. Duplication of the 22q11.2 region associated with congenital cardiac disease. Cardiol Young. 2005;15:229–231
  11. Goldmuntz E. The epidemiology and genetics of congenital heart disease. Clin Perinatol. 2001;28:1–10
  12. Goldmuntz E. The genetic contribution to congenital heart disease. Pediatr Clin North Am. 2004;51:1721–1737
  13. Manning N, Kaufman L, Roberts P. Genetics of cardiological disorders. Semin Fetal Neonatal Med. 2005;10:259–269
  14. Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol. 1994;23:1468–1471
  15. Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol. 1994;23:1459–1467
  16. Driscoll DJ. Evaluation of the cyanotic newborn. Pediatr Clin North Am. 1990;37:1–23
  17. Johnson JJ. Plethora and pallor. In:  Thureen PJ,  Deacon J,  Hernandez JA,  Hall DM editor. Assessment and care of the well newborn. 2nd ed.. St. Louis (Mo): Elsevier Saunders; 2005;p. 255–260
  18. Zahka KG, Gruenstein DH. Approach to the neonate with cardiovascular disease. In:  Martin RJ,  Fanaroff AA,  Walsh MC editor. Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. 8th ed.. Philadelphia (Pa): Mosby Elsevier; 2006;p. 1215–1222
  19. Theorell C. Cardiovascular assessment of the newborn. Newborn Infants Nurs Rev. 2002;2:111–127
  20. Witt C. Skin assessment. In:  Tappero EP,  Honeyfield ME editor. Physical assessment of the newborn: a comprehensive approach to the art of physical examination. 3rd ed.. Santa Rosa (Calif): NICU INK Book Publishers; 2003;p. 41–54
  21. Weis CM, Cox CA, Fox WW. Oxygen therapy. In:  Spitzer AR editors. Intensive care of the fetus and neonate. 2nd ed.. Philadelphia (Pa): Elsevier Mosby; 2005;p. 607
  22. Reich JD, Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003;142:268–272
  23. Koppel RI, Druschel CM, Carter T, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics. 2003;111:451–455
  24. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26:832–835
  25. Arlettaz R, Bauschatz AS, Monkhoff M, et al. The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr. 2006;165:94–98
  26. Knowles R, Griebsch I, Dezateux C, et al. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2005;9:1–168
  27. Marino BS, Wernovsky G. Preoperative and postoperative care of the infant with critical congenital heart disease. In:  Avery GB,  Fletcher MA,  MacDonald MG editor. Neonatalogy: pathophysiology and management of the newborn. 5th ed.. Philadelphia (Pa): Lippincott Williams & Wilkins; 1999;p. 647–698
  28. Hsu DT, Gersony WM. Medical management of congenital heart disease. In:  Spitzer AR editors. Intensive care of the fetus and neonate. 2nd ed.. Philadelphia (Pa): Elsevier Mosby; 2005;p. 929–938
  29. Gajewski KK. Cardiology. In:  Robertson J,  Shilkofski N editor. The Harriet Lane handbook: a manual for pediatric house officers. 17th ed.. Philadelphia (Pa): Elsevier Mosby; 2005;p. 194
  30. Crossland DS, Furness JC, Abu-Harb M, et al. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed. 2004;89:F325–F327
  31. Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol. 2001;28:91–136
  32. Sadowski SL. Cardiovascular disorders. In:  Verklan MT,  Walden M editor. Core curriculum for neonatal intensive care nursing. 3rd ed.. St. Louis (Mo): Elsevier Saunders; 2004;p. 584–642
  33. Montoya KD, Washington RL. Cardiovascular diseases and surgical interventions. In:  Merenstein GB,  Gardner SL editor. Handbook of neonatal intensive care. 5th ed.. St. Louis (Mo): Mosby; 2002;p. 576–608
  34. Pelech AN. The physiology of cardiac auscultation. Pediatr Clin North Am. 2004;51:1515–1535
  35. Moore KL, Persaud TVN. The developing human: clinically oriented embryology. 6th ed.. Philadelphia (Pa): W.B. Saunders Company; 1998;
  36. Johnson BA, Ades A. Delivery room and early postnatal management of neonates who have prenatally diagnosed congenital heart disease. Clin Perinatol. 2005;32:921–946
  37. Tworetzky W, Marshall AC. Fetal interventions for cardiac defects. Pediatr Clin North Am. 2004;51:1503–1513
  38. Westmoreland D. Critical congenital cardiac defects in the newborn. J Perinat Neonatal Nurs. 1999;12:67–87
  39. Pickert CB, Moss MM, Fiser DH. Differentiation of systemic infection and congenital obstructive left heart disease in the very young infant. Pediatr Emerg Care. 1998;14:263–267
  40. Artman M, Mahony L, Teitel DF. Neonatal cardiology. New York: McGraw-Hill; 2002;
  41. Kohr LM, O'Brien P. Current management of congestive heart failure in infants and children. Nurs Clin North Am. 1995;30:261–290
  42. Wolfson BJ. Radiologic interpretation of congenital heart disease. Clin Perinatol. 2001;28:71–89
  43. Rowland DG, Gutgesell HP. Noninvasive assessment of myocardial contractility, preload, and afterload in healthy newborn infants. Am J Cardiol. 1995;75:818–821
  44. Barlow AJ, Ward C, Webber S, et al. Myocardial contractility in premature neonates with and without patent ductus arteriosus. Pediatr Cardiol. 2004;25:102–107
  45. Friedman AH, Fahey JT. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease. Semin Perinatol. 1993;17:106–121
  46. Burton DA, Cabalka AK. Cardiac evaluation of infants: the first year of life. Pediatr Clin North Am. 1994;41:991–1015
  47. Colletti JE, Homme JL, Woodridge DP. Unsuspected neonatal killers in emergency medicine. Emerg Med Clin North Am. 2004;22:929–960
  48. Russo P, Russo JG. Congenital heart defects in newborns and infants: cardiothoracic repair. In:  Spitzer AR editors. Intensive care of the fetus and neonate. 2nd ed.. Philadelphia (Pa): Elsevier Mosby; 2005;p. 939–953
  49. American Academy of Pediatrics , American Heart Association . Neonatal resuscitation textbook. 5th ed.. Author; 2006;
  50. Sacchetti A, Wernovsky G, Paston C, Fernandes M. Hypoventilation and hypoxia in reversal of cardiogenic shock in an infant with congenital heart disease. Emerg Med J. 2004;21:636–638
  51. Toth B, Becker A, Seelbach-Gobel B. Oxygen saturation in healthy newborn infants immediately after birth measured by pulse oximetry. Arch Gynecol Obstet. 2002;266:105–107
  52. Dimich I, Singh PP, Adell A, et al. Evaluation of oxygen saturation monitoring by pulse oximetry in neonates in the delivery room. Can J Anaesth. 1991;38:985–988
  53. Zellers TM, Dixon K, Moake L, et al. Bedside balloon atrial septostomy is safe, efficacious, and cost-effective compared with septostomy performed in the cardiac catheterization laboratory. Am J Cardiol. 2002;89:613–615
  54. Jamjureeruk V, Sangtawesin C, Layangool T. Balloon atrial septostomy under two-dimensional echocardiographic control: a new outlook. Pediatr Cardiol. 1997;18:197–200
  55. Castaneda AR, Jonas RA, Mayer JE, Hanley FL. Cardiac surgery of the neonate and infant. Philadelphia (Pa): W.B. Saunders; 1994;
  56. Taketomo CK, Hodding JH, Kraus DM. Lexi-comp's pediatric dosage handbook. 11th ed.. Hudson (Ohio): Lexi-Comp; 2004;
  57. Young TE, Mangum B. Neofax: a manual of drugs used in neonatal care. 18th ed.. Raleigh (NC): Acorn Publishing; 2005;
  58. Zenk KE, Sills JH, Koeppel RM. Neonatal medications and nutrition: a comprehensive guide. 3rd ed.. Santa Rosa (Calif): NICU INK Book Publishers; 2003;
  59. Hallidie-Smith KA. Prostaglandin E1 in suspected ductus dependent cardiac malformation. Arch Dis Child. 1984;59:1020–1026
  60. Kramer HH, Sommer M, Rammos S, Krogmann O. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease. Eur J Pediatr. 1995;154:700–707
  61. Lim DS, Kulik TJ, Kim DW, et al. Aminophylline for the prevention of apnea during prostaglandin E1 infusion. Pediatrics. 2003;112:e27–e29
  62. Penny DJ, Shekerdemian LS. Management of the neonate with symptomatic congenital heart disease. Arch Dis Child Fetal Neonatal Ed. 2001;84:F141–F145
  63. Blackburn ST. Maternal, fetal, and neonatal physiology: a clinical perspective. 2nd ed.. St. Louis (Mo): Saunders; 2003;
  64. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. 2003;CD001242
  65. Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr. 2002;140:183–191
  66. Rigo J, De Curtis M. Disorders of calcium, phosphorus, and magnesium metabolism. In:  Martin RJ,  Fanaroff AA,  Walsh MC editor. Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. 8th ed.. Philadelphia (Pa): Mosby Elsevier; 2006;p. 1491–1523
  67. Cohn JK. An empirical study of parents' reaction to the diagnosis of congenital heart disease in infants. Soc Work Health Care. 1996;23:67–79
  68. Miles MS, Funk SG, Kasper MA. The neonatal intensive care unit environment: sources of stress for parents. AACN Clin Issues Crit Care Nurs. 1991;2:346–354
  69. Dudek-Shriber L. Parent stress in the neonatal intensive care unit and the influence of parent and infant characteristics. Am J Occup Ther. 2004;58:509–520
  70. Clark SM, Miles MS. Conflicting responses: the experiences of fathers of infants diagnosed with severe congenital heart disease. J Soc Pediatr Nurs. 1999;4:7–14
  71. Lobo ML, Michel Y. Behavioral and physiological responses during feeding in infants with congenital heart disease: a naturalistic study. Prog Cardiovasc Nurs. 1995;10:26–34
  72. Gardner FV, Freeman NH, Black AM, Angelini GD. Disturbed mother-infant interaction in association with congenital heart disease. Heart. 1996;76:56–59
  73. Uzark K, Jones K. Parenting stress and children with heart disease. J Pediatr Health Care. 2003;17:163–168
  74. Upham M, Medoff-Cooper B. What are the responses and needs of mothers of infants diagnosed with congenital heart disease?. MCN Am J Matern Child Nurs. 2005;30:24–29

PII: S1527-3369(06)00059-6

doi: 10.1053/j.nainr.2006.05.003

Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages 137-150 , September 2006

Article Tools

* Image Usage & Resolution